Clinical scofflaws?
These 29 sponsors of clinical trials failed to submit results by the legal deadline, or at all within the 20-month window Science examined, for all of their studies. For the 216 trials that were due, results for two-thirds were still unreported as of 25 September 2019, the end of that window. Only 17% of the 216 trials had submitted results that passed National Institutes of Health quality control and appear on ClinicalTrials.gov. This list includes only sponsors with at least five due trials.
Sponsor – number of trials
- Abramson Cancer Center, University of Pennsylvania – 11
- Acerta Pharma – 7
- Actavis – 6
- Barbara Ann Karmanos Cancer Institute – 5
- Baylor College of Medicine – 13
- Boston Children’s Hospital – 5
- Braeburn Pharmaceuticals – 5
- Cairo University – 10
- Case Comprehensive Cancer Center – 11
- Cutera Inc. – 11
- Edwards Lifesciences – 8
- Fox Chase Cancer Center – 7
- GTx – 6
- Jonsson Comprehensive Cancer Center, University of California, Los Angeles – 5
- Lundquist Institute for Biomedical Innovation – 5
- Medical College of Wisconsin – 6
- Medstar Health Research Institute – 5
- Northwell Health – 7
- Otonomy – 5
- Pacira Pharmaceuticals – 5
- St. Joseph’s Hospital and Medical Center – 5
- The Cooper Health System – 5
- University of Texas, Dallas – 6
- University Hospitals Cleveland Medical Center – 6
- University of Cincinnati – 8
- University of Minnesota – 14
- University of Nebraska – 5
- University of South Florida – 7
- University of Southern California – 10
*Correction, 22 January, 4:45 p.m.: The University of Maryland, College Park, has been removed from this list. Four studies from another sponsor were inadvertently added to its total: without them it drops below the five-trial minimum.
